Phytotherapy Research
Return to Library
|
Free Phytotherapy Research Articles |
|
|
|
|
Study data from University of Freiburg, Medical Department provide new insights into phytotherapy
2009 JUL 14 - (NewsRx.com) -- "In a retrospective evaluation of patients taking part for 2 months in a postmarketing surveillance study on the effectiveness and safety of Harpagophytum procumbens, associations were found to known explanators of pain, disability and depression," scientists writing in the journal Phytotherapy Research report. "Therefore, treatment non-responders might best be referred to a multimodal pain relief program that deals with fear avoidance beliefs, enhances experiences that decrease perceptions linking disability and pain and forces the patients to rethink the way they deal with the problem," wrote J. Thanner and colleagues, University of Freiburg, Medical Department. The researchers concluded: "However, during treatment with the aqueous Harpagophytum extract, this decision might reasonably be postponed to the end of month 4, since it has been shown that the maximum pain relief occurs after 3-4 months." Thanner and colleagues published their study in Phytotherapy Research (Retrospective Evaluation of Biopsychosocial Determinants and Treatment Response in Patients Receiving Devil's Claw Extract (Doloteffin(R)). Phytotherapy Research, 2009;23(5):742-744). Additional information can be obtained by contacting S. Chrubasik, University of Freiburg, Institute Forens Medical, Dept. of Forens Medical, Albertstr 9, D-79104 Freiburg, Germany. The publisher of the journal Phytotherapy Research can be contacted at: John Wiley & Sons Ltd., the Atrium, Southern Gate, Chichester PO19 8SQ, W Sussex, England. Keywords: Germany, Freiburg, Life Sciences, Biotechnology, Phytotherapy Research, Pain Management, Alternative Medicine, Therapy, Treatment, Psychosocial, University of Freiburg, Medical Department. This article was prepared by Science Letter editors from staff and other reports. Copyright 2009, Science Letter via NewsRx.com.
|
